Attenuation of leptin and insulin signaling by SOCS proteins

Trends in Endocrinology and Metabolism

Volumn 17, Issue 9, 2006, Pages 365-371

  Howard, Jane K ^a,b   Flier, Jeffrey S ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 6; SUPPRESSOR OF CYTOKINE SIGNALING 7; UNCLASSIFIED DRUG;

AGE; ENERGY BALANCE; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HORMONE RESISTANCE; INFLAMMATION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; INSULIN; LEPTIN; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; RECEPTOR, INSULIN; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 33750153292     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2006.09.007     Document Type: Review

References (57)

1. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
2. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
3. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
4. Starr R., et al. A family of cytokine-inducible inhibitors of signaling. Nature 387 (1997) 917-921
5. Endo T.A., et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 (1997) 921-924
6. Naka T., et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387 (1997) 924-929
7. Kile B.T., and Alexander W.S. The suppressors of cytokine signaling (SOCS). Cell. Mol. Life Sci. 58 (2001) 1627-1635
8. Nakagawa R., et al. SOCS1 participates in negative regulation of LPS responses. Immunity 17 (2002) 677-687
9. Emanuelli B., et al. SOCS3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275 (2000) 15985-15991
10. Krebs D.L., and Hilton D.J. A new role for SOCS in insulin action. Sci. STKE 169 (2003) PE6
11. Masuhara M., et al. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239 (1997) 439-446
12. Yasukawa H., et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18 (1999) 1309-1320
13. Krebs D.L., and Hilton D.J. SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 113 (2000) 2813-2819
14. Zhang J.G., et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteosomal degradation. Proc. Natl. Acad. Sci. U S A. 96 (1999) 2071-2076
15. Tartaglia L.A. The leptin receptor. J. Biol. Chem. 272 (1997) 6093-6096
16. Bjorbaek C., et al. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 4 (1998) 619-625
17. Bjorbaek C., et al. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274 (1999) 30059-30065
18. Wang Z.W., et al. The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 15 (2001) 108-114
19. Wang Z., et al. Leptin resistance in adipocytes in obesity: role of suppressors of cytokine signaling. Biochem. Biophys. Res. Commun. 277 (2000) 20-26
20. Banks A.S., et al. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275 (2000) 14563-14572
21. Bjorbak C., et al. SOCS-3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275 (2000) 40649-40657
22. Dunn S.L., et al. Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol. Endocrinol. 19 (2005) 925-938
23. Marine J.-C., et al. SOCS-3 is essential in the regulation of fetal liver erythropoiesis. Cell 98 (1999) 617-627
24. Howard J.K., et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10 (2004) 734-738
25. Mori H., et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10 (2004) 739-743
26. Munzberg H., et al. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 (2004) 4880-4889
27. Kievit P., et al. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 2 (2006) 123-132
28. Schwartz M.W., et al. Central nervous system control of food intake. Nature 404 (2000) 661-671
29. Bruning J.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
30. Spanswick D., et al. Insulin activates ATP-sensitive K+ channels in hypothalamic neurones of lean, but not obese rats. Nat. Neurosci. 3 (2000) 757-758
31. Spanswick D., et al. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390 (1997) 521-525
32. Kim Y.B., et al. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141 (2000) 2328-2339
33. Withers D.J. Insulin receptor substrate proteins and neuroendocrine function. Biochem. Soc. Trans. 29 (2001) 525-529
34. Rice K.M., et al. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 190 (1993) 961-967
35. Sun X.J., et al. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48 (1999) 1359-1364
36. Hotamisligil G.S., et al. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 271 (1996) 665-668
37. Aguirre V., et al. The c-Jun NH(2) terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J. Biol. Chem. 275 (2000) 9047-9054
38. Gao Z., et al. Serine phosphorylation of insulin receptor substrate-1 inhibitor kappa B kinase complex. J. Biol. Chem. 277 (2002) 48115-48121
39. Takano A., et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Diabetes 50 (2001) 1891-1900
40. Folli F., et al. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J. Clin. Invest. 100 (1997) 2159-2169
41. Shi H., et al. Suppressor of cytokine signaling-3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem. 279 (2004) 34733-34740
42. Steppan C.M., et al. Activation of SOCS-3 by resistin. Mol. Cell. Biol. 25 (2005) 1569-1575
43. Mooney R.A., et al. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. J. Biol. Chem. 276 (2001) 25889-25893
44. Emanuelli B., et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J. Biol. Chem. 276 (2001) 47944-47949
45. Ueki K., et al. Suppressors of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24 (2004) 5434-5446
46. Ueki K., et al. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. U S A 101 (2004) 10422-10427
47. Senn J.J., et al. Suppressors of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278 (2003) 13740-13746
48. Shi H., et al. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55 (2006) 699-707
49. Rui L., et al. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
50. Banks A.S., et al. Deletion of Socs7 leads to enhanced insulin action and enlarged islets of Langerhans. J. Clin. Invest. 115 (2005) 2462-2471
51. Starr R., et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. U S A 95 (1998) 14395-14399
52. Kawazoe Y., et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193 (2001) 263-269
53. Kawaguchi T., et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 165 (2004) 1499-1508
54. Steppan C.M., and Lazar M.A. The current biology of resistin. J. Intern. Med. 255 (2004) 439-447
55. Krebs D.L., et al. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell. Biol. 22 (2002) 4567-4578
56. Li L., et al. Insulin induces SOCS6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improved glucose metabolism. J. Biol. Chem. 279 (2004) 34107-34114
57. Terauchi Y., et al. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase. Nat. Genet. 21 (1999) 230-235